Search

Search Constraints

You searched for: Author/Creator Keating, Anne

Search Results

1. A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma. Issue 8 (2nd August 2016)

2. A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma. (23rd December 2014)